Murphy Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,940
| Closed | -$205K | – | 250 |
|
|
2019
Q1 | $205K | Buy |
+3,940
| New | +$205K | 0.03% | 236 |
|
|
2018
Q4 | – | Sell |
-4,540
| Closed | -$227K | – | 245 |
|
|
2018
Q3 | $227K | Sell |
4,540
-380
| -8% | -$19K | 0.03% | 247 |
|
|
2018
Q2 | $247K | Sell |
4,920
-40
| -0.8% | -$2.01K | 0.04% | 244 |
|
|
2018
Q1 | $242K | Sell |
4,960
-200
| -4% | -$9.76K | 0.03% | 236 |
|
|
2017
Q4 | $228K | Buy |
5,160
+1,000
| +24% | +$44.2K | 0.03% | 242 |
|
|
2017
Q3 | $211K | Sell |
4,160
-320
| -7% | -$16.2K | 0.03% | 256 |
|
|
2017
Q2 | $241K | Hold |
4,480
| – | – | 0.04% | 239 |
|
|
2017
Q1 | $236K | Buy |
4,480
+240
| +6% | +$12.6K | 0.04% | 252 |
|
|
2016
Q4 | $204K | Buy |
+4,240
| New | +$204K | 0.03% | 263 |
|
|
2015
Q4 | – | Sell |
-4,414
| Closed | -$212K | – | 318 |
|
|
2015
Q3 | $212K | Sell |
4,414
-1,840
| -29% | -$88.4K | 0.04% | 273 |
|
|
2015
Q2 | $325K | Sell |
6,254
-1,142
| -15% | -$59.3K | 0.05% | 249 |
|
|
2015
Q1 | $426K | Buy |
7,396
+2
| +0% | +$115 | 0.06% | 225 |
|
|
2014
Q4 | $395K | Sell |
7,394
-1,494
| -17% | -$79.8K | 0.06% | 233 |
|
|
2014
Q3 | $510K | Buy |
8,888
+242
| +3% | +$13.9K | 0.08% | 203 |
|
|
2014
Q2 | $577K | Sell |
8,646
-548
| -6% | -$36.6K | 0.09% | 195 |
|
|
2014
Q1 | $614K | Buy |
9,194
+963
| +12% | +$64.3K | 0.1% | 188 |
|
|
2013
Q4 | $549K | Sell |
8,231
-158
| -2% | -$10.5K | 0.1% | 196 |
|
|
2013
Q3 | $526K | Buy |
8,389
+135
| +2% | +$8.47K | 0.1% | 184 |
|
|
2013
Q2 | $515K | Buy |
+8,254
| New | +$515K | 0.1% | 179 |
|